IMPLANT SITE CELLULITIS

This adverse event was reported 234 times

These drugs are most commonly taken by patients reporting IMPLANT SITE CELLULITIS:

# Drug Count
0 ETONOGESTREL 157
1 BACLOFEN 13
2 ACETAMINOPHEN 6
3 ASPIRIN 6
4 ASPIRIN 325 MG 6
5 ASPIRIN 81 MG 6
6 IBUPROFEN 6
7 METFORMIN 6
8 SERTRALINE 6
9 BACLOFEN INJECTION 5
See all common drugs associated with IMPLANT SITE CELLULITIS

IMPLANT SITE CELLULITIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 LIDOCAINE, EPINEPHRINE 1 0.1250
1 SODIUM PHOSPHATE, DIBASIC AND SODIUM PHOSPHATE, MONOBASIC 1 0.0122
2 HISTRELIN ACETATE 4 0.0046
3 FIRST AID ANTIBIOTIC 1 0.0042
4 ETONOGESTREL 157 0.0027
5 BACLOFEN INJECTION 5 0.0016
6 MINERAL OIL 1 0.0007
7 ZICONOTIDE ACETATE 1 0.0004
8 TRIAMTERENE AND HYDROCHLOROTHIAZIDE 2 0.0003
9 ZIPRASIDONE 1 0.0003
See all drugs enriched for association with IMPLANT SITE CELLULITIS

IMPLANT SITE CELLULITIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Progestin [EPC] 158 0.0005
1 Guanylate Cyclase-C Agonist [EPC] 1 0.0005
2 gamma-Aminobutyric Acid-ergic Agonist [EPC] 18 0.0002
3 Potassium-sparing Diuretic [EPC] 2 0.0001
4 Androgen [EPC] 4 0.0001
5 Stimulant Laxative [EPC] 1 0.0001
6 Provitamin D2 Compound [EPC] 2 0.0001
7 Nitrofuran Antibacterial [EPC] 1 0.0001
8 Leukotriene Receptor Antagonist [EPC] 1 0.0000
9 BCL-2 Inhibitor [EPC] 2 0.0000
See all drug classes enriched for association with IMPLANT SITE CELLULITIS